RD

Ravikiran Devineni

Active Director Director DIN 07246563
DIN 07246563 First appointment Jul 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2015
Shareholding value •••• Premium profile

About Ravikiran Devineni

Data last updated:

Ravikiran Devineni is a Director at Darwin Pharma Private Limited (since 2015). The company operates in Pharma. Darwin Pharma Private Limited reported revenue of ₹1.33 Cr (FY 2016).

DIN 07246563
Primary Designation Director
Industry Pharma
First Appointment 15 Jul 2015
Oldest Company Age 17 yrs
Largest company Darwin Pharma Private Limited · ₹1.33 Cr (FY 2016)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Darwin Pharma Private Limited U51397AP2009PTC064584
Director15 Jul 20152009₹1.33 Cr (FY 2016)Active

Board colleagues of Ravikiran Devineni

Directorship timeline

Open interactive timeline →
Darwin Pharma Private Limited
Premium access

Shareholding and investment profile for Ravikiran Devineni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravikiran Devineni

Ravikiran Devineni currently holds 1 directorship: Darwin Pharma Private Limited (Director, since 15 Jul 2015, revenue ₹1.33 Cr (FY 2016)).

Ravikiran Devineni was first appointed on 15 Jul 2015 as Director at Darwin Pharma Private Limited.

The current boards of Ravikiran Devineni's companies include China Venkata Ratnam Surasani (Darwin Pharma Private Limited), Raja Sekhara Reddy Lankeyreddy (Darwin Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available